Chelbi Yasmine, Meftah Khaoula, Deghmane Ala-Eddine, Mhimdi Samar, Aloui Firas, Bouafsoun Aida, Hong Eva, Menif Khaled, Boussetta Khadija, Khemiri Monia, Boukthir Samir, Trifa Mehdi, Jlidi Said, Jouini Riadh, Fitouri Zohra, Nessib Mohamed-Nabil, Taha Muhamed-Kheir, Smaoui Hanen
Laboratory of Microbiology, Children's Hospital of Tunis, Beb Saadoun, Tunis 1007, Tunisia.
Faculty of Medicine, University of Tunis El Manar, Beb Saadoun, Tunis 1007, Tunisia.
Microorganisms. 2024 Dec 23;12(12):2666. doi: 10.3390/microorganisms12122666.
The changing epidemiological profile of invasive infections (IIHi) is noted in the post-vaccination era. The aim of this study was to characterize phenotypically and genotypically invasive (Hi) isolates detected in Tunisian pediatric patients. A retrospective study was conducted in the microbiology laboratory of the Children's Hospital of Tunis over ten years (2013-2023). All IIHi cases were included. Molecular identification and serotyping were conducted through qPCR. Molecular typing and analysis of resistance genes were extracted from whole genome sequencing data. Fifty-three IIHi cases were collected. Children under five years old were the most affected (81%). Non-typable isolates (NTHi) were predominant (79%) followed by serotype b (17%) and serotype a (4%). Genetic diversity was observed, essentially among NTHi isolates. Resistance of Hi isolates to ampicillin, amoxicillin-clavulanic acid and cefotaxime (CTX) were 42%, 20% and 4%, respectively. Thirteen isolates (29%) produced a beta-lactamase and 14 carried the gene (kappa = 0.95). For non-enzymatic resistance, group 3 (n = 12) showed resistance to ampicillin. Groupe 4 (n = 9, NTHi) showed discordances with resistance to CTX. The emergence of resistance to CTX is concerning. Continuous surveillance through molecular tools in conjunction with phenotypic and clinical data is necessary to ensure better management of these infections.
疫苗接种后时代侵袭性感染(IIHi)的流行病学特征正在发生变化。本研究的目的是对突尼斯儿科患者中检测到的侵袭性(Hi)分离株进行表型和基因型特征分析。在突尼斯儿童医院的微生物实验室进行了一项为期十年(2013 - 2023年)的回顾性研究。纳入了所有IIHi病例。通过qPCR进行分子鉴定和血清分型。从全基因组测序数据中提取分子分型和耐药基因分析。共收集到53例IIHi病例。五岁以下儿童受影响最大(81%)。不可分型分离株(NTHi)占主导(79%),其次是b血清型(17%)和a血清型(4%)。观察到了基因多样性,主要存在于NTHi分离株中。Hi分离株对氨苄西林、阿莫西林 - 克拉维酸和头孢噻肟(CTX)的耐药率分别为42%、20%和4%。13株分离株(29%)产生β - 内酰胺酶,14株携带该基因(kappa = 0.95)。对于非酶促耐药,第3组(n = 12)对氨苄西林耐药。第4组(n = 9,NTHi)对CTX耐药存在不一致情况。对CTX耐药的出现令人担忧。通过分子工具结合表型和临床数据进行持续监测对于确保更好地管理这些感染是必要的。